Pfizer Takes Big Loss From Reduced Use of Their 'COVID-19 Vaccines and Therapies'
Originally posted on VigilantNews.com
In light of recent financial results, Pfizer, one of the key producers of the COVID-19 vaccine, is undergoing substantial changes in its revenue and earnings outlook for 2023. The pharmaceutical titan recently announced a revised projected earnings per share (EPS) for FY23, cutting its previously projected $3.25-$3.4…
Keep reading with a 7-day free trial
Subscribe to The Conservative Compass to keep reading this post and get 7 days of free access to the full post archives.